Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response

被引:11
作者
Florkowski, CM [1 ]
Barnard, R
Livesey, JH
Veveris, T
Espiner, EA
Donald, RA
机构
[1] Christchurch Hosp, Dept Endocrinol, Christchurch, New Zealand
[2] Queensland Univ Technol, Cooperat Res Ctr Diagnost Technol, Brisbane, Qld 4001, Australia
[3] Queensland Univ Technol, Ctr Mol Biol, Brisbane, Qld 4001, Australia
关键词
growth hormone binding protein; leptin; body fat;
D O I
10.1054/ghir.1998.0084
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
GH-binding protein (GHBP) corresponds to the extracellular domain of the GH receptor (GHR) and has been shown to be closely related to body fat. This study aimed to examine the inter-relationship between GHBP, leptin and body fat, and to test the hypothesis that GHBP is modified by GH replacement in GH-deficient adults and predicts IGF-I response. Twenty adults, mean age 47 years (range 20-69) with proven GH deficiency were randomly allocated to either GH (up to 0.25 U/kg/week in daily doses) or placebo for 3 months before cross-over to the opposite treatment. Plasma GHBP and leptin were measured at baseline and 2, 4, 8 and 12 weeks after each treatment. Whole body composition was measured at baseline by dual-energy X-ray absorptiometry (DEXA). There was a strong correlation between baseline leptin and GHBP (r = 0.88, P < 0.0001) and between baseline GHBP and percentage body fat, (r = 0.83, P < 0.0001). Mean GHBP levels were higher on GH compared with placebo, 1.53 +/- 0.28 vs 1.41 +/- 0.25 nM, P = 0.049. There was no correlation between baseline IGF-I and GHBP (r = -0.049, P = 0.84), and GHBP did not predict IGF-I response to GH replacement. The close inter-relationship between GHBP, leptin and body fat suggests a possible role for GHBP in the regulation of body composition. GHBP is increased by GH replacement in GH-deficient adults, but does not predict biochemical response to GH replacement. (C) 1999 Churchill Livingstone.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 39 条
[31]  
Rasat R, 1996, NEW ZEAL MED J, V109, P156
[32]   HIGH-AFFINITY GROWTH-HORMONE BINDING-PROTEIN IN PLASMA OF PATIENTS WITH ACROMEGALY AND THE EFFECT OF OCTREOTIDE TREATMENT [J].
ROELEN, CAM ;
DONKER, GH ;
THIJSSEN, JHH ;
KOPPESCHAAR, HPF ;
BLANKENSTEIN, MA .
CLINICAL ENDOCRINOLOGY, 1992, 37 (04) :373-378
[33]   Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein [J].
Roelen, CAM ;
Koppeschaar, HPF ;
deVries, WR ;
Snel, YEM ;
Doerga, ME ;
Zelissen, PMJ ;
Thijssen, JHH ;
Blankenstein, MA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) :760-764
[34]   INCREASED BODY-FAT MASS AND DECREASED EXTRACELLULAR FLUID VOLUME IN ADULTS WITH GROWTH-HORMONE DEFICIENCY [J].
ROSEN, T ;
BOSAEUS, I ;
TOLLI, J ;
LINDSTEDT, G ;
BENGTSSON, BA .
CLINICAL ENDOCRINOLOGY, 1993, 38 (01) :63-71
[35]   THE EFFECTS OF TREATMENT WITH RECOMBINANT HUMAN GROWTH-HORMONE ON BODY-COMPOSITION AND METABOLISM IN ADULTS WITH GROWTH-HORMONE DEFICIENCY [J].
SALOMON, F ;
CUNEO, RC ;
HESP, R ;
SONKSEN, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (26) :1797-1803
[36]   MAGNETIC-RESONANCE IMAGING-ASSESSED ADIPOSE-TISSUE AND SERUM-LIPID AND INSULIN CONCENTRATIONS IN GROWTH HORMONE-DEFICIENT ADULTS - EFFECT OF GROWTH-HORMONE REPLACEMENT [J].
SNEL, YEM ;
DOERGA, ME ;
BRUMMER, RJM ;
ZELISSEN, PMJ ;
KOPPESCHAAR, HPF .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (10) :1543-1548
[37]   DIFFERENTIAL REGULATION OF SERUM GROWTH-HORMONE (GH)-BINDING PROTEIN DURING CONTINUOUS-INFUSION VERSUS DAILY INJECTION OF RECOMBINANT HUMAN GH IN GH-DEFICIENT CHILDREN [J].
TAUBER, M ;
DUPORTAL, HD ;
SALLERINCAUTE, B ;
ROCHICCIOLI, P ;
BASTIDE, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (05) :1135-1139
[38]   Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: Correlation with GH insensitivity [J].
Tonshoff, B ;
Cronin, MJ ;
Reichert, M ;
Haffner, D ;
Wingen, AM ;
Blum, WF ;
Mehls, O ;
Ratsch, I ;
Michelis, K ;
Kapogiannis, T ;
Lennert, T ;
Jung, F ;
Gellert, S ;
Tulassay, T ;
Sallay, P ;
vonLilien, T ;
Querfeld, U ;
vonWendtGoknur, MA ;
Bonzel, KE ;
Gusmano, R ;
Verrina, E ;
Offner, G ;
FabianBach, C ;
Appiani, A ;
Bettinelli, A ;
Feber, J ;
Picca, S ;
Rizzoni, G ;
Stolpe, HJ ;
Wigger, W ;
KistvanHolthe, J ;
Wolff, E ;
Berg, U ;
Fischbach, M ;
Dobos, E ;
Balzar, E ;
Neuhaus, T ;
Ruder, H ;
Scheller, B ;
Dippell, J ;
Zimmerhackl, LB ;
Wuhl, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1007-1013
[39]   Recombinant human growth hormone-binding protein fails to enhance the in vivo bioactivity of human growth hormone in normal rats [J].
Tzanela, M ;
Wagner, C ;
Tannenbaum, GS .
ENDOCRINOLOGY, 1997, 138 (12) :5316-5324